Isolation
of circulating tumor cells (CTCs) in peripheral blood from cancer
patients bears critical importance for evaluation of therapeutic efficacy.
The current CTC isolation strategies are majorly relying on either
protein biomarkers or dimensional features of CTCs. In this study,
we present a new methodology for CTC detection and isolation based
on the surface charge of cancer cells, a bioelectrical manifestation
of the “Warburg effect.” Negative surface charge is
a direct consequence of glycolysis of cancer cells, which can be utilized
as an effective biophysical marker for CTC detection and isolation.
Upon cancer cells–nanoparticle interaction via optimum incubation,
serum protein-coated electrically charged nanoparticles can trap different
cancer cells independent of their epithelial protein expression. In
fetal bovine serum , the poly(ethyleneimine)-functionalized Fe3O4 nanoparticles, surface-decorated with protein
corona, are able to efficiently capture CTCs from blood samples of
colorectal cancer patients. 2–8 CTCs has been isolated
from 1 mL of blood and identified by immunostaining fluorescence
in situ hybridization and immunofluorescence staining in all 25 colorectal
cancer patients at varied stages, while only 0–1 CTC was detected
from blood samples of 10 healthy donors. Diverse CTC subpopulations
of heteroploids and biomarker expression can also be detected in this
strategy. The label-free, charge-based CTC method shows promise in
cancer diagnosis and prognosis paving a new path for liquid biopsy.